当前位置:首页 - 行情中心 - 维康药业(300878) - 财务分析 - 现金流量表

维康药业

(300878)

  

流通市值:40.43亿  总市值:40.61亿
流通股本:1.44亿   总股本:1.45亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金159,513,871.68120,832,916.2158,473,216.71405,624,104.44
  收到的税费返还2,140,993.42---
  收到其他与经营活动有关的现金49,703,801.6343,375,360.124,454,213.7919,585,170.72
  经营活动现金流入小计211,358,666.73164,208,276.3362,927,430.5425,209,275.16
  购买商品、接受劳务支付的现金37,395,340.6625,761,819.5516,814,483.26154,860,164.73
  支付给职工以及为职工支付的现金54,844,130.4738,017,402.7122,139,470.47108,799,940.21
  支付的各项税费7,533,625.277,347,676.371,309,120.8230,667,913.59
  支付其他与经营活动有关的现金68,604,102.0548,676,31229,152,911.66158,054,263.98
  经营活动现金流出小计168,377,198.45119,803,210.6369,415,986.21452,382,282.51
  经营活动产生的现金流量净额42,981,468.2844,405,065.7-6,488,555.71-27,173,007.35
二、投资活动产生的现金流量:
  收回投资收到的现金---241,000,000
  取得投资收益收到的现金---6,757,427.79
  处置固定资产、无形资产和其他长期资产收回的现金净额50,00050,000-4,507,876.73
  处置子公司及其他营业单位收到的现金净额44,625,315.6844,625,315.6844,625,315.6837,316,314.84
  收到的其他与投资活动有关的现金---25,631,784.6
  投资活动现金流入小计44,675,315.6844,675,315.6844,625,315.68315,213,403.96
  购建固定资产、无形资产和其他长期资产支付的现金28,716,102.9221,766,524.9721,376,558.04126,923,321.16
  支付其他与投资活动有关的现金10,000,00010,000,0009,257,400.33-
  投资活动现金流出小计38,716,102.9231,766,524.9730,633,958.37126,923,321.16
  投资活动产生的现金流量净额5,959,212.7612,908,790.7113,991,357.31188,290,082.8
三、筹资活动产生的现金流量:
  取得借款收到的现金11,000,00011,000,00011,000,000189,013,455
  筹资活动现金流入小计11,000,00011,000,00011,000,000189,013,455
  偿还债务支付的现金25,261,33525,261,33510,000,000316,950,000
  分配股利、利润或偿付利息支付的现金25,328,395.4124,004,842.312,304,651.3144,399,822.39
  支付其他与筹资活动有关的现金---61,753,702.54
  筹资活动现金流出小计50,589,730.4149,266,177.3112,304,651.31423,103,524.93
  筹资活动产生的现金流量净额-39,589,730.41-38,266,177.31-1,304,651.31-234,090,069.93
五、现金及现金等价物净增加额9,350,950.6319,047,679.16,198,150.29-72,972,994.48
  加:期初现金及现金等价物余额253,609,333.79253,609,333.79253,609,333.79326,582,328.27
  期末现金及现金等价物余额262,960,284.42272,657,012.89259,807,484.08253,609,333.79
补充资料:
  净利润--64,311,059.43--144,878,375.29
  资产减值准备--1,542,952.71-93,442,845.29
  固定资产和投资性房地产折旧-27,711,026.25-66,117,784
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,711,026.25-66,117,784
  无形资产摊销-890,357.91-1,956,846.53
  长期待摊费用摊销-30,288.74-1,593,049.9
  处置固定资产、无形资产和其他长期资产的损失-493,861.61-467,667.6
  固定资产报废损失-1,295-61,894.79
  财务费用-3,782,750.26-9,335,228.93
  投资损失-0--91,118,107.02
  递延所得税-6,779,378.07--21,383,440.66
  其中:递延所得税资产减少-6,826,723.44--27,595,876.11
    递延所得税负债增加--47,345.37-6,212,435.45
  存货的减少-10,252,134.7--7,147,432.93
  经营性应收项目的减少-75,788,133.9-72,918,581.21
  经营性应付项目的增加--16,114,654.3--8,539,549.7
  现金的期末余额-272,657,012.89-253,609,333.79
  减:现金的期初余额-253,609,333.79-326,582,328.27
  现金及现金等价物的净增加额-19,047,679.1--72,972,994.48
公告日期2025-10-302025-08-282025-04-292025-04-29
审计意见(境内)保留意见
TOP↑